company background image
BOIR.F logo

Boiron OTCPK:BOIR.F Stock Report

Last Price

US$35.85

Market Cap

US$612.3m

7D

0%

1Y

n/a

Updated

13 Oct, 2024

Data

Company Financials +

Boiron SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Boiron
Historical stock prices
Current Share Price€35.85
52 Week High€46.22
52 Week Low€32.90
Beta0.46
11 Month Change0%
3 Month Change3.91%
1 Year Changen/a
33 Year Changen/a
5 Year Change-0.42%
Change since IPO55.53%

Recent News & Updates

Recent updates

Shareholder Returns

BOIR.FUS PharmaceuticalsUS Market
7D0%-3.4%-1.3%
1Yn/a17.1%30.7%

Return vs Industry: Insufficient data to determine how BOIR.F performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how BOIR.F performed against the US Market.

Price Volatility

Is BOIR.F's price volatile compared to industry and market?
BOIR.F volatility
BOIR.F Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.1%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market3.0%

Stable Share Price: BOIR.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine BOIR.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19322,788Thierry Boironwww.boiron.fr

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain.

Boiron SA Fundamentals Summary

How do Boiron's earnings and revenue compare to its market cap?
BOIR.F fundamental statistics
Market capUS$612.28m
Earnings (TTM)US$25.91m
Revenue (TTM)US$526.75m

23.6x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BOIR.F income statement (TTM)
Revenue€481.71m
Cost of Revenue€130.85m
Gross Profit€350.87m
Other Expenses€327.18m
Earnings€23.69m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.36
Gross Margin72.84%
Net Profit Margin4.92%
Debt/Equity Ratio1.1%

How did BOIR.F perform over the long term?

See historical performance and comparison

Dividends

4.2%

Current Dividend Yield

99%

Payout Ratio